These interactions highlight the need for customized approaches when starting GLP-1 therapy, ensuring that your treatment plan aligns with your specific health needs
13 : 1319 Prickaerts J, Blokland A, Honig W, Meng F, Jolles J
While both are modified versions of naturally occurring IGF-1, they have different structures, half-lives, and applications, making them suitable for different goals
If symptoms persist or become more severe, halting the GLP-1 receptor agonist dose titration and assessing the patient for the presence of underlying conditions may be advised
The doctor also touched on why a weight loss drug that does not cause muscle loss is so important: Preserving muscle mass is important in any kind of weight loss